Atossa Therapeutics, Inc. (ATOS)
NASDAQ: ATOS · Real-Time Price · USD
4.780
0.00 (0.00%)
At close: Mar 11, 2026, 4:00 PM EDT
4.734
-0.046 (-0.97%)
After-hours: Mar 11, 2026, 7:51 PM EDT

Atossa Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
51.8571.0888.46110.89136.3839.55
Cash & Short-Term Investments
51.8571.0888.46110.89136.3839.55
Cash Growth
-30.66%-19.64%-20.23%-18.69%244.79%214.39%
Other Receivables
---0.741.070.64
Total Trade Receivables
---0.741.070.64
Other Current Assets
3.833.373.766.563.792.58
Total Current Assets
55.6874.4692.22118.2141.2442.77
Net Property, Plant & Equipment
-----0.04
Other Intangible Assets
-----0.01
Long-Term Investments
--1.714.7--
Other Long-Term Assets
2.331.992.320.640.020.02
Total Assets
58.0176.4496.25123.53141.2642.84
Accounts Payable
3.540.680.812.971.721.59
Accrued Expenses
3.112.782.632.581.391.06
Current Portion of Leases
-----0.02
Other Current Liabilities
1.581.511.80.020.0213.01
Total Current Liabilities
8.234.975.245.573.1315.67
Total Liabilities
8.234.975.245.573.1315.67
Common Stock
23.4923.4922.7922.7922.798.56
Treasury Stock
-1.48-1.48-1.48---
Additional Paid-in Capital
263.4261.26255.99251.37244.58130.51
Retained Earnings
-235.63-211.79-186.29-156.19-129.23-111.9
Shareholders' Equity
49.7971.4891.02117.96138.1427.17
Total Liabilities & Equity
58.0176.4496.25123.53141.2642.84
Total Debt
-00000.02
Net Cash (Debt)
51.8571.0888.46110.89136.3839.54
Net Cash Growth
-27.07%-19.64%-20.23%-18.69%244.94%215.51%
Net Cash Per Share
6.058.4710.5213.1417.4952.44
Book Value
49.7971.4891.02117.96138.1427.17
Book Value Per Share
5.818.5210.8313.9717.7236.04
Tangible Book Value
49.7971.4891.02117.96138.1427.16
Tangible Book Value Per Share
5.818.5210.8313.9717.7236.02
Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q